SG Americas Securities’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-947,797
| Closed | -$5.68M | – | 2650 |
|
2025
Q1 | $5.68M | Sell |
947,797
-16,915
| -2% | -$101K | 0.02% | 393 |
|
2024
Q4 | $7.53M | Buy |
964,712
+932,179
| +2,865% | +$7.27M | 0.03% | 239 |
|
2024
Q3 | $351K | Buy |
+32,533
| New | +$351K | ﹤0.01% | 1778 |
|
2024
Q2 | – | Sell |
-14,750
| Closed | -$99K | – | 2494 |
|
2024
Q1 | $99K | Sell |
14,750
-302,659
| -95% | -$2.03M | ﹤0.01% | 2283 |
|
2023
Q4 | $1.87M | Buy |
317,409
+212,687
| +203% | +$1.25M | 0.02% | 634 |
|
2023
Q3 | $1.02M | Buy |
104,722
+65,843
| +169% | +$642K | 0.01% | 1158 |
|
2023
Q2 | $460K | Sell |
38,879
-121,962
| -76% | -$1.44M | ﹤0.01% | 1263 |
|
2023
Q1 | $1.74M | Buy |
160,841
+138,148
| +609% | +$1.49M | 0.02% | 676 |
|
2022
Q4 | $262K | Sell |
22,693
-1,774
| -7% | -$20.5K | ﹤0.01% | 1818 |
|
2022
Q3 | $365K | Buy |
24,467
+7,418
| +44% | +$111K | ﹤0.01% | 1617 |
|
2022
Q2 | $154K | Buy |
+17,049
| New | +$154K | ﹤0.01% | 2595 |
|
2021
Q4 | – | Sell |
-19,307
| Closed | -$162K | – | 3018 |
|
2021
Q3 | $162K | Buy |
+19,307
| New | +$162K | ﹤0.01% | 3099 |
|